medroxyprogesterone has been researched along with Cancer of the Vulva in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H | 1 |
| Lévy, G; Muller, P | 1 |
2 other study(ies) available for medroxyprogesterone and Cancer of the Vulva
| Article | Year |
|---|---|
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms | 2014 |
[Hormones and genital cancer in women].
Topics: Adult; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Ovarian Neoplasms; Progesterone; Testosterone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1969 |